FREE SHIPPING ON ORDERS OVER $150

buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S-Transferase π Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione (∗) L-Buthionine-(S,R)-Sulfoximine (BSO, NSC 326231, CAS

$29.82

Quantity
- +
Description

Liu JJ, Huang Z, Zhang R, Zhang Q, Sun Z, Zhang Y, Liu B, Ma

buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S-Transferase  Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () L-Buthionine-(S,R)-Sulfoximine (BSO, NSC 326231, CAS

Importantly, PKD activity was almost completely abolished in PKD3-deficient mice (Fig 4F)

buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S-Transferase  Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () L-Buthionine-(S,R)-Sulfoximine (BSO, NSC 326231, CAS

Key Benefits Promotes deep, natural sleep cycles and improved REM balance May help reduce stress and cortisol levels Supports recovery from fatigue and mental exhaustion Potential role in regulating circadian rhythms May assist with growth hormone release during sleep Can support immune and hormonal balance Mechanism of Action DSIP 5mg acts on the hypothalamus and pituitary gland, modulating the release of various neurohormones such as corticotropin, growth hormone, and melatonin

buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S-Transferase  Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () L-Buthionine-(S,R)-Sulfoximine (BSO, NSC 326231, CAS

Aquat Toxicol 52:189203 Costa J, Ferreira M, Rey-Salgueiro L, Reis-Henriques MA (2011) Comparison of the waterborne and dietary routes of exposure on the effects of benzo(a)pyrene on biotransformation pathways in Nile tilapia ( Oreochromis niloticus )

buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S-Transferase  Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () L-Buthionine-(S,R)-Sulfoximine (BSO, NSC 326231, CAS

Researchers attribute ES2s effectiveness to its ability to bind to FOXO4, thereby disrupting the interaction between FOXO4 and p53 [128]

buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S-Transferase  Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () L-Buthionine-(S,R)-Sulfoximine (BSO, NSC 326231, CAS

Currently, its FDA-approved only for treating methemoglobinemia, although doctors also use it off-label for other conditions

buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S-Transferase  Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () L-Buthionine-(S,R)-Sulfoximine (BSO, NSC 326231, CAS

You may also like

recommand products